Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

DYAI

Dyadic (DYAI)

Dyadic International Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DYAI
FechaHoraFuenteTítuloSímboloCompañía
28/06/202407:30GlobeNewswire Inc.Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization PartnershipNASDAQ:DYAIDyadic International Inc
13/06/202420:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DYAIDyadic International Inc
11/06/202415:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DYAIDyadic International Inc
06/06/202416:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DYAIDyadic International Inc
30/05/202415:30GlobeNewswire Inc.Dyadic to Attend Industry Events in JuneNASDAQ:DYAIDyadic International Inc
14/05/202415:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DYAIDyadic International Inc
14/05/202415:00GlobeNewswire Inc.Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:DYAIDyadic International Inc
08/05/202407:30GlobeNewswire Inc.Dyadic to Attend Industry and Investor Events in MayNASDAQ:DYAIDyadic International Inc
07/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DYAIDyadic International Inc
30/04/202415:30GlobeNewswire Inc.Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024NASDAQ:DYAIDyadic International Inc
28/03/202415:00GlobeNewswire Inc.Dyadic Reports 2023 Full Year Results and Recent Company ProgressNASDAQ:DYAIDyadic International Inc
28/03/202407:30GlobeNewswire Inc.Dyadic Announces Change in Board and Management Leadership RolesNASDAQ:DYAIDyadic International Inc
27/03/202407:30GlobeNewswire Inc.Dyadic to Attend Industry Events in AprilNASDAQ:DYAIDyadic International Inc
26/03/202407:30GlobeNewswire Inc.Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature CommunicationsNASDAQ:DYAIDyadic International Inc
21/03/202407:30GlobeNewswire Inc.Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, CaliforniaNASDAQ:DYAIDyadic International Inc
14/03/202415:30GlobeNewswire Inc.Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024NASDAQ:DYAIDyadic International Inc
11/03/202408:57GlobeNewswire Inc.CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationNASDAQ:DYAIDyadic International Inc
11/03/202407:30GlobeNewswire Inc.Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationNASDAQ:DYAIDyadic International Inc
01/03/202407:30GlobeNewswire Inc.Dyadic to Attend Industry Events in MarchNASDAQ:DYAIDyadic International Inc
28/02/202407:30GlobeNewswire Inc.Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production PlatformNASDAQ:DYAIDyadic International Inc
21/02/202407:30GlobeNewswire Inc.Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsNASDAQ:DYAIDyadic International Inc
13/02/202415:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DYAIDyadic International Inc
13/02/202407:30GlobeNewswire Inc.Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in BiomanufacturingNASDAQ:DYAIDyadic International Inc
06/02/202407:30GlobeNewswire Inc.Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical CompanyNASDAQ:DYAIDyadic International Inc
01/02/202407:30GlobeNewswire Inc.Dyadic to Attend BIO CEO & Investor Conference and European Industry EventsNASDAQ:DYAIDyadic International Inc
02/01/202407:30GlobeNewswire Inc.Dyadic to Attend J.P. Morgan 42nd Annual Healthcare ConferenceNASDAQ:DYAIDyadic International Inc
30/11/202307:30GlobeNewswire Inc.Dyadic Attends Investor Events in DecemberNASDAQ:DYAIDyadic International Inc
29/11/202307:30GlobeNewswire Inc.Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine CandidateNASDAQ:DYAIDyadic International Inc
20/11/202307:30GlobeNewswire Inc.Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in AfricaNASDAQ:DYAIDyadic International Inc
08/11/202315:00GlobeNewswire Inc.Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:DYAIDyadic International Inc
 Showing the most relevant articles for your search:NASDAQ:DYAI

Su Consulta Reciente